Background
•




•




•

•
1990


1998


2001


2002









Competitor Analysis










¸
¸
¸

¸
¸
ED Market Share
Physicians
•

•

•
Patients
•
•
•
Average Age of ED Patients

                                      60



                                      58
                 Family doctor

3% 5% 0%                              56
                 Urologist or men`s
                 specialist
           49%                        54
43%              Cardiologist
                                           58.4
                                      52
                                                                                      56.9
                 Psychiatrist
                                                                      55.4
                                      50                      53.5
                 Internet doctor
                                                    50.7                       50.7
                                      48


                                      46
                                           US      France   Germany   Italy   Spain   UK
Health Care Transaction Model (HCTM)
•



    Perceived   Consult their                             Actually take    Intend to
                                 Receive a     Fill the
    they have   doctor about                                  the             refill
                                perception   perception
    condition    condition                                 medication     prescription



•

•

•
My spouse or sex patner

                                    Newspaper or magazine
             22%
                             29%    TV, radio or movie commercial

1% 2%
                                    A TV or radioshow
2%

        6%                    15%   A newspaper or magazine ad
  3%
             5%
   2%              9%   4%
                                    A friend or relative

                                    Something that was mailed to me

                                    A sex counselor or psychologist
Barriers to Seeking Treatment                                   Barriers to Seeking Treatment
                    (ages 20-39)                                                    (ages 40-49)
                                        Waiting to see if the                                                Waiting to see if the
                                        condition will go                                                    condition will go away
           3%    7%                     away
     9%                                                              3%         14%
                            21%         Doesn`t happen all                                  18%              Doesn`t happen all that
3%                                                              5%
                                        that often                                                           often
5%                                                              6%
                                                                                                    21%
          15%                     21%
                                        Embarrassed to talk               10%                                Embarrassed to talk
                      16%                                                             19%
                                        about it                4%                                           about it


                                        Don`t want to take                                                   Don`t want to take
                                        drugs for this                                                       drugs for this condition
                                        condition


          Barriers to Seeking Treatment                                   Barriers to Seeking Treatment
                    (ages 50-59)                                                    (ages 60+)

                                        Waiting to see if the                                                Waiting to see if the
                                        condition will go                              11%              8%   condition will go away
                20%         21%         away                              32%
5%                                                                                                  10%
                                        Doesn`t happen all                                                   Doesn`t happen all that
                                  18%
                                        that often                                                           often
7%                                                                                                14%
                10%     13%                                                     12%
1%
                                        Embarrassed to talk          8%                                      Embarrassed to talk
     5%                                 about it                                                             about it
                                                                                       3%     3%
US
France
Germany
Italy
Spain
UK




Problem Analysis
 How Cialis gain market share and compete with
  existing market leader Viagra?
 Should Cialis be priced higher or lower than Viagra?
 How Cialis choosing the strategy to compete with
  Viagra :
      - Niche strategy
      - Direct compete (head to head competition)
      - Beat strategy (differential Positioning)
SWOT Analysis
S                                             W
TRENGTHS                                            EAKNESSES
           • The absorption of the drug
             was not affected by food                      • Cialis is a new entrance
             intake                                        • Low Compound Annual
           • Cialis has a shorter onset                      Growth Rates (CAGR) in
             time and the effects up to                      Germany and France.
             36 hours.                                       This may lead to low
           • Rare incidence of visual                        return in these markets.
             irregularities                                • The banned direct-to-          Internal
           • Record submission time of                       consumer in Europe             factors
             Phase III to FDA                                will lead to inconsistency
           • Has a great Global                              in the marketing and
             Marketing Sales organization                    present greater difficulties
             to improve Cialis                               in targeting in countries.




O                                             T
PPORTUNITIES                                      HREATS
           • High CAGR n the
             US, UK, Italy, Spain, Canada
             , Mexico and Brazil. There is                 •Viagra and Levitra as
             a opportunity to gain market                   current competitor
             share in these regions.                       •Upcoming new competitor
           • The high dropout rates of                     •Bad experience of using         External
             Viagra after first year offers                 Cialis                          factors
             potential targeting for Lilly                 •Barriers to seeking
             ICOS LLC.                                      treatment
           • Current Viagra users and                      •Viagra well positioned and
             dropouts user willing to try                   well known, but Cialis
             Cialis                                         unknown
           • Positioning by considering
             love and intimacy
STP Cialis
                                                                 •Age :
                                                                    •Core Target Age
             • Men with Erectile Dysfunction in
                                                                     50 – 59, 60+ age
Segmenting




                                                                                          Positioning
                                                                                                        • Cialis, for male
               United States and Europe




                                                     Targeting
               (France, Germany, Italy, Spain, and
               United Kingdom) and age 20 – 65
                                                                    group
               years old.
                                                                    •Additional Target                    who suffer from
                                                                    Age  20 – 39                         Erectile
                                                                 •Income : Middle to                      Dysfunction will
                                                                 Low                                      help you to be
                                                                 •Employment :                            more intimate
                                                                 Employed full time                       with your partner
                                                                 and retired                              and quality of life
                                                                 •Marital status                          because of its
                                                                                                          durability, shorter
                                                                   •Primary : Married
                                                                   or Living together
                                                                                                          onset and
                                                                   (76,5%)                                flexibility with
                                                                                                          meal taken.
                                                                   •Secondary :
                                                                   Single, Never
                                                                   married (10,5%) &
                                                                   Divorce or separated
                                                                   (10,3%)
Product
     Product

Brand name :              Cialis
Form :                    Tablet
Serving size :            10 mg, 20 mg
Cialis is only available with a prescription and have to consult with Primary
care physician/ urologist first.
Product
       Price

 Slightly lower than Viagra ($10/pill)
 Cialis set the price on $ 9 / pill
    To attract people that Cialis is better than Viagra even the price is
    less. It has better durability and more safety because all product are
    sell with doctor prescription.
Product
           Price
  Net Sales Growth
Net Sales        1996         1997         1998          1999          2000         Average
Growth                                                                              Net Sales
Percentage -                  15,9%        8,4%          7,32%         9,58%        10,3%
Growth
In Millions      7.346,6      8.517,6      9.236,8       9.912,9       10.862,2     -

  Forecast
Forecast Net       Year 1         Year 2          Year 3 (15%      Year 4 (20%    Year 5 (25%
Sales (From                                       Growth)          Growth)        Growth)
average 10,3%)

In Millions        11.948,2       13.178,9        15.155.735       18.186,9       22.733,6
Product
     Place
☺Drug store
☺Clinical Pharmacy
☺Hospital Pharmacy
☺ Online Pharmacy
Promotion

Below the line
•


•
Promotion

Above the line

Promotion

Above the line
Promotion

Above the line




    

    
Promotion
Above the line






    
    
    
    
CONCLUSION
Cialis

Cialis

  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
    Average Age ofED Patients 60 58 Family doctor 3% 5% 0% 56 Urologist or men`s specialist 49% 54 43% Cardiologist 58.4 52 56.9 Psychiatrist 55.4 50 53.5 Internet doctor 50.7 50.7 48 46 US France Germany Italy Spain UK
  • 14.
    Health Care TransactionModel (HCTM) • Perceived Consult their Actually take Intend to Receive a Fill the they have doctor about the refill perception perception condition condition medication prescription • • •
  • 15.
    My spouse orsex patner Newspaper or magazine 22% 29% TV, radio or movie commercial 1% 2% A TV or radioshow 2% 6% 15% A newspaper or magazine ad 3% 5% 2% 9% 4% A friend or relative Something that was mailed to me A sex counselor or psychologist
  • 16.
    Barriers to SeekingTreatment Barriers to Seeking Treatment (ages 20-39) (ages 40-49) Waiting to see if the Waiting to see if the condition will go condition will go away 3% 7% away 9% 3% 14% 21% Doesn`t happen all 18% Doesn`t happen all that 3% 5% that often often 5% 6% 21% 15% 21% Embarrassed to talk 10% Embarrassed to talk 16% 19% about it 4% about it Don`t want to take Don`t want to take drugs for this drugs for this condition condition Barriers to Seeking Treatment Barriers to Seeking Treatment (ages 50-59) (ages 60+) Waiting to see if the Waiting to see if the condition will go 11% 8% condition will go away 20% 21% away 32% 5% 10% Doesn`t happen all Doesn`t happen all that 18% that often often 7% 14% 10% 13% 12% 1% Embarrassed to talk 8% Embarrassed to talk 5% about it about it 3% 3%
  • 17.
  • 18.
  • 19.
  • 20.
     How Cialisgain market share and compete with existing market leader Viagra?  Should Cialis be priced higher or lower than Viagra?  How Cialis choosing the strategy to compete with Viagra : - Niche strategy - Direct compete (head to head competition) - Beat strategy (differential Positioning)
  • 21.
    SWOT Analysis S W TRENGTHS EAKNESSES • The absorption of the drug was not affected by food • Cialis is a new entrance intake • Low Compound Annual • Cialis has a shorter onset Growth Rates (CAGR) in time and the effects up to Germany and France. 36 hours. This may lead to low • Rare incidence of visual return in these markets. irregularities • The banned direct-to- Internal • Record submission time of consumer in Europe factors Phase III to FDA will lead to inconsistency • Has a great Global in the marketing and Marketing Sales organization present greater difficulties to improve Cialis in targeting in countries. O T PPORTUNITIES HREATS • High CAGR n the US, UK, Italy, Spain, Canada , Mexico and Brazil. There is •Viagra and Levitra as a opportunity to gain market current competitor share in these regions. •Upcoming new competitor • The high dropout rates of •Bad experience of using External Viagra after first year offers Cialis factors potential targeting for Lilly •Barriers to seeking ICOS LLC. treatment • Current Viagra users and •Viagra well positioned and dropouts user willing to try well known, but Cialis Cialis unknown • Positioning by considering love and intimacy
  • 22.
    STP Cialis •Age : •Core Target Age • Men with Erectile Dysfunction in  50 – 59, 60+ age Segmenting Positioning • Cialis, for male United States and Europe Targeting (France, Germany, Italy, Spain, and United Kingdom) and age 20 – 65 group years old. •Additional Target who suffer from Age  20 – 39 Erectile •Income : Middle to Dysfunction will Low help you to be •Employment : more intimate Employed full time with your partner and retired and quality of life •Marital status because of its durability, shorter •Primary : Married or Living together onset and (76,5%) flexibility with meal taken. •Secondary : Single, Never married (10,5%) & Divorce or separated (10,3%)
  • 23.
    Product Product Brand name : Cialis Form : Tablet Serving size : 10 mg, 20 mg Cialis is only available with a prescription and have to consult with Primary care physician/ urologist first.
  • 24.
    Product Price  Slightly lower than Viagra ($10/pill)  Cialis set the price on $ 9 / pill To attract people that Cialis is better than Viagra even the price is less. It has better durability and more safety because all product are sell with doctor prescription.
  • 25.
    Product Price  Net Sales Growth Net Sales 1996 1997 1998 1999 2000 Average Growth Net Sales Percentage - 15,9% 8,4% 7,32% 9,58% 10,3% Growth In Millions 7.346,6 8.517,6 9.236,8 9.912,9 10.862,2 -  Forecast Forecast Net Year 1 Year 2 Year 3 (15% Year 4 (20% Year 5 (25% Sales (From Growth) Growth) Growth) average 10,3%) In Millions 11.948,2 13.178,9 15.155.735 18.186,9 22.733,6
  • 26.
    Product Place ☺Drug store ☺Clinical Pharmacy ☺Hospital Pharmacy ☺ Online Pharmacy
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.

Editor's Notes

  • #16 Variety of factor that ED patients want to seek treatment, with spouse or sex partners is the most highly cited (29%)
  • #17 Younger man expressed higher level of embarrassment in talking about the condition and were waiting to go awayFor older men the belief that this was a normal phenomenon of aging seemed to create reluctance to seek treatmentFor those who seek treatment, Viagra was the most commonly suggested medication.
  • #18  As we can see, the Viagra current users and viagra dropout has a large percentage that represent they willing to try Cialis in U.S and Europe
  • #27 Drug store & Pharmaceutical StoreEasier for customer to fill the prescription after consulting with physician.Doctor ClinicHelping the consumer who get confuse about the medicine so they can get the right prescription after consulting with physician. Online Pharmacy : facilitate the ED patient who couldn’t go to local drugstore or find Cialis by simply fill it online.